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UbiquitinationThe amount of transcription factor OCT4 is strictly regulated. A tight regulation of OCT4 levels is crucial for
mammalian embryonic development and oncogenesis. However, the mechanisms underlying regulation of
OCT4 protein expression and nuclear distribution are largely unknown. Here, we report that DPF2, a plant
homeodomain (PHD) ﬁnger protein, is upregulated during H9 cell differentiation induced by retinoic acid.
Endogenous interaction between DPF2 and OCT4 in P19 cells was revealed by an immunoprecipitation assay.
GST-pull down assay proved that OCT4 protein in H9 cells and recombinant OCT4 can precipitate with DPF2
in vitro. In vitro ubiquitination assay demonstrated DPF2 might serve as an E3 ligase. Knock down of dpf2 using
siRNA increased OCT4 protein level and stability in P19 cells. DPF2 siRNAs also up-regulates OCT4 but not
NANOG in H9 cells. However, RA fails to downregulates OCT4 protein level in cells infected by lenitviruses
containing DPF2 siRNA. Moreover, overexpression of both DPF2 and OCT4 in 293 cells proved the DPF2–OCT4
interaction. DPF2 but not PHD2 mutant DPF2 enhanced ubiquitination and degradation of OCT4 in 293 cells co-
expressed DPF2 andOCT4. Bothwild type DPF2 and PHD2mutant DPF2 redistributes nuclear OCT4without affect-
ing DPF2–OCT4 interaction. Further analysis indicated that DPF2 decreases monomeric and mono-ubiquitinated
OCT4, assembles poly-ubiquitin chains on OCT4 mainly through Ub–K48 linkage. These ﬁndings contribute to an
understanding of how OCT4 protein level and nuclear distribution is regulated by its associated protein.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
OCT4 plays crucial roles in maintaining stem cell pluripotency [1–3].
A critical amount of OCT4 is required to sustain embryonic stem cell
(ESC) self-renewal and multilineage differentiation capacity [4]. OCT4
is required for generating induced pluripotent stem cells (iPSCs) [5–7].
OCT4 alone is sufﬁcient to generate iPSCs with the aid of small
molecules [8,9]. Moreover, OCT4 also plays roles in oncogenesis and
may be a potential target for drug therapy of cancer [10–13]. Spatially,
OCT4 subnuclear distribution is related to oncogenesis [14,15]. Recent
report also showed that OCT4 nucleocytoplasmic dynamics is involved
in cell reprogramming and self-renewal of ESCs [16]. In addition, nuclear
localization of OCT4 is required for its transactivating activity [17].ed pluripotent stem cell; PHD,
teasome system; E3, ubiquitin
one S-transferase; RA, retinoic
noblotting; IF, immunoﬂuores-
and Embryology, 69 Meishan
na.
ang@umaryland.edu (S. Fang).Therefore, understanding regulation of OCT4protein level and intracellu-
lar localization may contribute to manipulating OCT4 relevant function
and further application.
The ubiquitin (Ub) proteasome system (UPS) is a proteolytic system
that regulates protein levels through ubiquitination of its targeted pro-
teins [18,19]. Ubiquitination is a process whereby a small protein, Ub,
conjugates its target protein. Mono-ubiquitination occurs through
isopeptide bond between the ε-amino group of the lysine (Lys, K) side
chain in target protein and the C-terminal glycine (Gly76) residue on
Ub, which is achieved through enzymatic cascade activation by E1
(Ub-activating), E2 (Ub-conjugating), and E3 (Ub-ligase) enzymes. The
addition of one or more Ub moieties to the ﬁrst Ub on the target sub-
strates results in di- or poly-ubiquitination [20]. Poly-ubiquitination, in-
stead of mono-ubiquitination, is targeted for proteasomal degradation
[21]. UPS thus plays crucial roles in many cellular processes [18],
includingmaintaining pluripotency of stem cells and determining devel-
opmental potency of various adult stem cells, through substrate
ubiquitination [22]. Recent report indicated that RNF2, an E3, interacts
with OCT4 and functions in maintaining stem cell pluripotency [23].
WWP2, another E3, also interacts with OCT4 and regulates OCT4 protein
level in human ESCs [24]. While fusion of a single Ub to OCT4 inactivates
its transcriptional activity [25], poly-ubiquitination of OCT4 decreases its
level [24]. Speciﬁcally, K48-linked poly-Ub chains instead of K63-linked
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[18,19]. In UPS, E3s interact directly with substrate proteins and thus
determine the substrate levels [18]. E3s also play crucial roles in
translocation of the related substrates [26,27]. Two main types of
E3s, homologous to the E6AP carboxyl terminus (HECT) and really in-
teresting new gene (RING) ﬁnger families of E3s, have been identiﬁed
[28,29]. HECT domain receives Ub from the E2 through a thiol linkage
to a conserved Cysteine and transfers it to substrate. The RING ﬁnger
marks the vast majority of E3s that play crucial roles in protein
degradation and chelate also two Zn2+ ions through a conserved set
of cysteines and histidines arranged in a Cysteine-3-Histidine-
Cysteine-4(C3HC4) pattern [28,29].
DPF2, also named ubi–d4/requiem (REQU), interacts with OCT4 or
a protein complex containing OCT4 in vivo [30–32]. It contains double
plant homeodomain (PHD) ﬁngers and is involved in cell apoptosis
[33,34] and also noncanonical NF-kappaB transcriptional activation
and its associated oncogenic activity [35]. PHD ﬁngers are zinc-
binding motifs that function in DNA binding, chromatin organization
and protein–protein interaction [36,37]. However, the exact function
of PHD ﬁngers remains elusive. Typical PHD ﬁngers contain a
Cysteine-4-Histidine-Cysteine-3(C4HC3) consensus that coordinates
two Zn2+ ions in a crossbrace topology [38], which is similar with
RING ﬁngers [28]. Therefore, PHD ﬁnger is considered as one subgroup
of RING-related E3s [28]. Indeed, more and more studies discovered
that PHD ﬁnger proteins function in ubiquitination and degradation
of target proteins [39–44], suggesting PHD ﬁnger proteins might
have shared an E3 activity. We therefore want to check if DPF2 directly
interacts with and functions in OCT4 stability and intracellular
localization.
In this study, we report that all-trans retinoic acid (RA) treatment
leads to down-regulation of OCT4 protein accompanied by up-
regulation of DPF2 in H9 cells. DPF2 interacts with OCT4 and serves as
an E3 ligase. dpf2 siRNA increased OCT4 protein level and stability in
P19 cells. DPF2 siRNA also up-regulates expression of OCT4 but not
NANOG inH9 cells. However, RA induced differentiation downregulates
OCT4 protein level in cells infected by lenitviruses containing control
siRNA but not DPF2 siRNA. Overexpression of DPF2 changes OCT4
subnuclear distribution and increasesOCT4ubiquitination anddegrada-
tion, and all of these processes depend on the second PHD ﬁnger of
DPF2. Further analysis indicated that DPF2 decreases monomeric and
mono-ubiquitinated OCT4, assembles poly-ubiquitin chains on OCT4
mainly through Ub–K48 linkage.
2. Materials and methods
2.1. Plasmids
The OCT4 plasmid previously described was provided as a gift from
Dr. Yun Qiu [6]. The wild-type (WT) DPF2 cDNA was constructed by
subcloning a PCR product ampliﬁed using primers 5′- CGGAATTCCCAT
GGAAGATGGCGGCTGTGGTGGAG-3′ and 5′-A CGCGTCGACCAAGAGG
AGTTCTGGTTCTGGTAGA-3′ from the pCMV-SPORT6-DPF2 (Open
Biosystems, Huntsville, AL) vector and was then cloned into pGEX-5X-
1 and pEGFP-N1 vectors via EcoRI/SalI sites. Wild type RNF2 cDNA
was ampliﬁed by PCR using primers 5′- CGGGATCCCGATGGCAATGTCT
CAGGCTGTGCAGAC-3′ and 5′-ACGCGTCGACCGTTTGTGCTCCTTTGTA
GGTGCGTAA-3′ from thepDNR-LIB-RNF2 (OpenBiosystems, Huntsville,
AL) vector and was then inserted into the pGEX-5X-1 vector via the
BamHI/SalI sites. pFLAG–CMV–6C–DPF2 was created by excising DPF2
via EcoRI/Sal sites from pEGFP–N1–DPF2 and cloned into the pFLAG–
CMV–6C vector. The following point mutations in the gene were intro-
duced using site-directed mutagenesis (Stratagene, La Jolla, CA): a
PHD2 mutant DPF2, DPF2 (M), was created using primers 5′-GATCGT
GGCTACGCCATGTACGCGTTAACCCCGTCCATG-3′ and 5′-CATGGACGGG
GTTAACGCGTACATGGCGTAGCCACGATC- 3′. A 6His-tagged Ub, a lysine
null mutant Ub, and a single-lysine-containing mutant Ub wereprovided as kind gifts from Dr. Yun Qiu. Plasmids encoding FLAG-
tagged Ub and HA-tagged Ub were provided as kind gifts from Dr.
Yihong Ye. A pET28a-OCT4 plasmid was provided as a kind gift from
Dr. Ying-jie Wang.
2.2. Cell culture
P19 cell was cultured as previously described [45]. HeLa and 293
culturing was previously described, respectively [46,47]. Brieﬂy, cells
were maintained in Dulbecco's modiﬁed Eagle's medium supplement-
ed with 10% foetal bovine serum, 50 units/ml penicillin, 50 μg/ml
streptomycin and glutamine under 5% CO2 in a humidiﬁed incubator.
Cells were transfected with plasmid DNA by using calcium phosphate
precipitation or Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Human
ESC line, H9, was maintained on Matrigel (BD Bioscience, Bedford,
MA) in mTeSR medium (Stem Cell Technologies, Vancouver, BC,
Canada), as previously described [48,49].
2.3. GST-pull down assay
Glutathione S-transferase (GST) fusions were expressed in log
phase Escherichia coli BL-21 (DE3) (Novagen, Madison, WI) that
were grown overnight at room temperature and induced with
0.1 mM isopropyl-1-thio-β-D-galactopyranoside for 1 h. Bacterial pel-
lets were resuspended in sonication buffer (50 mM Tris, pH 7.4,
1 mM EDTA, 1% Triton X-100, 5 mM DTT, 2 mM phenylmethylsulfonyl
ﬂuoride) and lysed by probe sonication, using 4 ml of sonication buffer
per 100 ml of bacterial culture. The sonicated lysate was clariﬁed by
centrifugation at 4 °C for 15 min at 14,000 rpm, aliquoted, and stored
at −70 °C. The GST fusion proteins were puriﬁed with glutathione-
Sepharose beads. His-tagged human OCT4 was expressed in
Escherichia coli BL-21 and puriﬁed using Ni-NTA agarose (QIAGEN,
Hilden, Germany) as described previously [50]. H9 cells were treated
with MG132 (Calbiochem) at 20 μM for 4 h and lysed in NP-40 lysis
buffer (150 mM NaCl, 10 mM Tris/HCl, pH 7.5, 1 mM EDTA, 1 mM
EGTA, 1 mM phenylmethylsulfonyl ﬂuoride, 0.2% NP-40). GST-DPF2
and/or GST-RNF2 immobilized on glutathione-Sepharose beads were
incubated with H9 cell lysates or recombinant His-tagged OCT4 over-
night at 4 °C. After washing with NP-40 lysis buffer, bead-associated
proteins were immunoblotted for OCT4. IB was performed following
the previously published protocol [51].
2.4. Immunoprecipitation (IP) and immunoblotting (IB)
Immunoprecipitation under native condition was performed as
previously described [51]. Brieﬂy, cells were harvested 18–20 h after
transfection and lysed in RIPA buffer (50 mM Tris/HCl, PH 8.0,
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
protease inhibitor cocktail, and 1 mM phenylmethylsulfonyl ﬂuoride)
with or without 20 μMMG132. Lysates were incubated with 2–3 μg of
primary antibody and 40 μl of protein A (Zymed) or Protein G (Roche
Diagnostics, Indianapolis, USA) Agarose overnight at 4 °C. Beads were
then washed three times in wash buffer containing 50 mM TrisHCl
(pH 7.5), 100 mM NaCl, and 0.5% Triton X-100 before processing for IB
as previously described [51]. For immunoprecipitation (IP) under dena-
tured condition, 10% of the harvested cells were lysed with RIPA lysis
buffer and kept for input. The other cellswere lysedwith buffer contain-
ing 1% SDS, 15U/mlDNAse, 5mMEDTA, 10mMDTT, heated for 5min at
95 °C, and then dilutedwith 9 volumes of RIPA lysis buffer. After incuba-
tion on ice for 5 min, the lysates were processed for IP followed by IB
assay as previously described [51]. Antibodies used for IB are as follows:
rabbit anti-DPF2 (1:5000, Lifespan Bioscience, Seattle,WA, USA),mono-
clonal rabbit anti-OCT4 (1:3000, Cell Signaling Technology, Danvers,
MA, USA), rabbit anti-DPF2 (1:500, Proteintech), rabbit anti-BIP
(1:1000, Cell Signaling Technology, Danvers, MA, USA), mouse anti-
VCP (1:5000), rabbit anti-GAPDH (1:5000), mouse anti-OCT4 (1:1000,
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(1:5000, Sigma, St. Louis, MO, USA), anti-FLAG–HRP (1:1000, Sigma,
St. Louis, MO, USA), mouse anti-Ub (1:500–1:2000, Santa Cruz Biotech-
nologies, Santa Cruz, CA, USA), mouse anti-GST (1:10,000, Proteintech),
and rabbit anti-NANOG (1:1000, abcam).
2.5. Fluorescence and immunoﬂuorescence (IF) assay
H9 cells were cultured on Matrigel coated coverslips. The other cells
were cultured on coverslips. Transfection was performed with the indi-
cated plasmids using Lipofectamine 2000 or calcium phosphate. Cells
were ﬁxed in 4% paraformaldehyde, washed with 1× phosphate-
buffered saline (PBS), and blocked for 60 min with 0.1% BSA in 1× PBS
containing 0.1% saponin. GFP-tagged proteins in 293 cells were
visualized under a ﬂuorescence microscope 16 h after transfection.
For FLAG-tagged proteins, transfected cells were labelled using a
Cy3-conjugated anti-FLAG (1:500, Sigma, St. Louis, MO) antibody.
Transfected OCT4 in 293 cells and HeLa cells were labelled with a rabbit
anti-OCT4 antibody followed by incubation with an Alexa Flour-488
(1:500) anti-rabbit antibody. For P19 and H9 cells, endogenous DPF2
and OCT4 were labelled using rabbit anti-DPF2 (1:100, Proteintech)
and mouse anti-OCT4 (1:1000, Santa Cruz Biotechnologies, Santa Cruz,
CA) antibodies followed by incubation with Alexa Fluor-488 anti-
mouse (1:500) and Alexa Fluor-594 anti-rabbit (1:500) antibodies.
Staining was performed as previously described [51]. A Zeiss Axiovert
200 M inverted ﬂuorescent microscope, an Olympus IX73 inverted ﬂuo-
rescent microscope and a NIKON Eclipse 80i ﬂuorescent microscope was
used for visualization.
2.6. dpf2 siRNA assay
Double-stranded oligonucleotides (GenePharma,Shanghai, China)
were designed against three separate regions of mouse dpf2 cDNA.
The sequences of these duplexes are: sense 5′-GCC CAG AGC AAU
UGU UAU ATT-3′ and antisense 5′-UAU AAC AAU UGC UCU GGG
CTT-3′ for dpf2 siRNA # 237; sense 5′-GCU UUC UUU CCC AUC GAU
UTT-3′ and antisense 5′-AAU CGA UGG GAA AGA AAG CTT-3′ for
dpf2 siRNA#370, sense 5′-GCG AGU UUC CUG UUA GCA ATT-3′ and an-
tisense 5′-UUG CUA ACA GGA AAC UCG CTT-3′ for dpf2 siRNA # 525.
Meanwhile, oligonucleotide targeting against mouse gapdh : sense
5′-CAC UCA AGA UUG UCA GCA ATT-3′ and antisense 5′-UUG CUG
ACA AUC UUG AGU GAG-3′ served as the positive control, whereas
an irrelevant oligonucleotide: sense 5′-UUC UCC GAA CGU GUC ACG
UTT-3′ and antisense 5′-ACG UGA CAC GUU CGG AGA ATT-3′ served
as the negative control (nc). P19 cells were transfected with mouse
siRNAs using lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA).The
transfection was performed when cells grew to reach 40–50% conﬂu-
ence as previously described [52]. At 12 h posttransfection, change
the culture medium with fresh complete medium. Cells were harvest-
ed 72 h after transfection followed by further analysis.
2.7. Lentiviral-vector mediated DPF2 siRNA
A lentivirus-mediated method to establish stable DPF2 siRNA H9
cell lines was modiﬁed according to a previously protocol [53]. Brieﬂy,
H9 cells were incubated in mTeSR supplemented with 10 mM Y-
27632 at 37 °C for 1 h. Then the cells were dissociated with accutase
(Millipore) at 37 °C for 5 min. After washing with mTeSR, the cells
were transfer to a 15 mL tube and centrifugated at 500 rpm/min at
RT. Then the cells were resuspended in 1 mL mTeSR supplemented
with 10 μl of concentrated GFP-expressing lentivirus containing DPF2
siRNAs (LV-DPF2 siRNA #25,540, #25,541 and #25,542) (Genechem,
Shanghai, China) and incubated at 37 °C for 1 h. Finally, the cell sus-
pension supplemented with 10 mM Y-27,632 was replated on
Matrigel-coated 6-well plates and placed gently into incubator.
Change medium with mTeSR daily for 5 days. Then apply selectiondrug puromycin at 10 μg/mL in mTeSR, change medium daily and se-
lect for 2 weeks. The stable H9 cell lines were cryopreserved in liquid
nitrogen after 3 passages. For transient lentivirus infection of H9 cells,
no puromycin selection was performed and a nontargeting siRNA
(Genechem, Shanghai, China) was used as a control. The detail infor-
mation of design of the DPF2 siRNAs is shown in Supplementary
Table 1.
2.8. Cycloheximide chase (CHX) assay
Cycloheximide chase experiments were performed as previously
described [51]. Brieﬂy, 24 h after transfection, 293 cells were incubated
for the indicated timeswith 100 μg/ml cycloheximide and processed for
IB with the indicated antibodies. P19 cells were also incubated for the
indicated times with 100 μg/ml cycloheximide 48 h after dpf2 siRNA
transfection.
2.9. In vivo ubiquitination assay
For endogenous OCT4 ubiquitination, H9 cells maintained on
Matrigel in mTeSR medium were treated with 20 μM MG132 for 6 h.
Cells were then subjected to denatured IP using control anti-goat anti-
bodies and anti-OCT4 antibodies to disrupt proteins that may associate
with OCT4, followed by IB for indicated proteins.
For ubiquitination of ectopic OCT4, cells were transfected with
plasmids encoding OCT4 with or without plasmids encoding HA–Ub,
along with or without wild-type (WT) FLAG–DPF2. After 16 h, cells
were treated with 20 μM MG132 for 6 h. Cells were then lysed with
RIPA buffer containing 5 mM N-ethylmaleimide (NEM), 20 μM
MG132, and lastly, 1% SDS, 15 U/ml DNAse, 5 mM EDTA, 10 mM DTT
were added to denature proteins. Lysates were diluted in RIPA buffer
with a ﬁnal concentration of 0.1% SDS and used for IP with an OCT4
antibody followed by IB for the indicated proteins.
2.10. H9 cell differentiation induced by all-trans retinoic acid (RA)
H9 cell differentiation induced by all-trans retinoic acid (RA, Sigma)
was performed according to our previous protocol [48]. H9 cells grew to
reach 60–70% conﬂuence were seeded in 6-well plates pre-coated with
Matrigel and maintained in mTeSR medium. The next day (d1), cells
were treated with all-trans retinoic acid (RA, Sigma) at 10 μM in fresh
mTeSR medium. For a 5-day induction, culture medium was refreshed
with mTeSR medium containing 10 μM every day. At d6, the H9 cells
were lysed and the lysates were subjected to IB. For a 29-day induction,
mTeSR1 medium contain 10 μM RA were replaced every other day.
Untreated H9 cells (d0) and cells treated for 5, 9, 14, 19 days, denoted
as d5, d9, d14 and d19, were harvested and stored at−80 °C. At d29,
all cells were lysed and the lysates were subject to IB for indicated
proteins. For differentiation of H9 cells infected by lentiviruses, the cells
were subjected to RA treatment for 0, 1, 3 days and harvested at different
time points for following IB assay.
2.11. Cytoplasmic and nuclear fraction assay
Cytoplasmic and nuclear fractionwas performed according to previ-
ous protocol [27]. Cells were harvested, rinsedwith phosphate-buffered
saline, and pelleted. The cells were then suspended in 5 volumes of cold
HB buffer (10 mM Tris, pH 7.9, 1.5 mM MgCl2, 10 mM KCl, protease
inhibitor cocktail) and allowed to swell on ice for 15 min, after which
Triton X-100 was added to a ﬁnal concentration of 0.2%. After vortexing
for 5 s, the homogenatewas spun for 10min at 1000 g. The supernatant,
containing the cytoplasmic fraction, was transferred to a fresh tube, and
the salt concentration was adjusted to 200 mM with 5 M NaCl. The
crude nuclear pellet was suspended in RIPA-lysis buffer containing 1%
Triton X-100 and 10% glycerol, and vortexed vigorously at 4 °C for
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Nuclear and cytoplasmic factions were analysed by IB as described.2.12. In vitro ubiquitination assay
Using the rabbit reticulocyte lysate (RRL) (Promega, untreated,
Madison, Wisconsin, USA) as a source of E1 and E2, the ubiquitination
assay of GST–DPF2 was performed as described previously [54]. Brieﬂy,
the reactionmixture (150 μl) containing 40mMTris–HCl, pH 7.5, 5 mM
MgCl2, 2 mM ATP, 2 mM dithiothreitol (DTT), 300 ng/μl ubiquitin
(Sigma, St. Louis, Missouri, USA), 25 μMMG132, 5 μl rabbit reticulocyte
lysate (Promega, Madison, Wisconsin, USA) and 600 ng GST or
GST–DPF2 was incubated at 30 °C for 3 h. Anti-OCT4 immunoprecipi-
tates obtained from H9 cell lysates were used as substrates for in vitro
ubiquitination assay according to a protocol described previously [55].
The precipitates were washed ﬁve times with lysis buffer, once with
ubiquitination buffer (40 mM Tris–HCl, 5 mM MgCl2, 2 mM ATP,
2 mM DTT) and subjected to in vitro ubiquitination. Finally, all samples
were eluted with SDS-sample buffer, resolved by 8% SDS-PAGE,
transferred to nitrocellulose membranes and subjected to IB with anti-
OCT4, anti-Ub and anti-GST antibodies.Fig. 1.Differential expression of DPF2 during H9 cell differentiation induced by RA. A–D, H9 cell
for 1 day and 5 days, respectively. Bar= 50 μm. E–H,H9 cells weremaintained onMatrigel inm
RA induction. A clump of crowded neural precursor cells after 19 days of RA induction (G). Scat
Bar=50 μm. I and J, TheH9 andH9 derived cellswere harvested at various time points and subj
RA was changed every day during the 5-day RA induction, or changed every other day during
DPF2 during the 5-day (K) RA induction and the 29-day (L) RA induction, respectively.3. Results
3.1. Different expression of DPF2 during early and late stage of H9 cell
differentiation induced by RA
RA induces stem cell differentiation and represses OCT4 expression
in stem cells [56]. To follow the fate of DPF2 during human ESC differen-
tiation, we treated H9 cells with RA for up to 29 days. Undifferentiated
H9 cell clusters were composed of densely packed monolayer cells
with clear rims (Fig. 1A). A 5-day culture led to the merging of clumps
without differentiation (Fig. 1B). After a treatment for 20 h with RA,
cells became ﬂatter, increased in size, and the rims were lost (Fig. 1C).
Derived cells proliferated faster thanH9 cells and assumed variousmor-
phologies (Fig. 1D). Neural tube-like structures were found in clumps
after RA induction for 14 days (Fig. 1F), and neuronal precursor cells
were found at day 19 of RA induction (Fig. 1G). Results of IB assay
indicated that DPF2 exhibits an initial down-regulation followed by
up-regulation (Fig. 1I). Notably, OCT4 protein was down-regulated sig-
niﬁcantly after a 5-day RA induction (Fig. 1I). Additionally, the disap-
pearance of OCT4 was accompanied by increased expression of DPF2
(Fig. 1I and J), which is consistent with that 293 cells and HeLa cells
expressedmore DPF2 as compared to undifferentiated H9 cells (Fig. S1).s maintained onMatrigel inmTeSR supplementedwith (C and D) or without (A and B) RA
TeSRmedium for 4 days (E). Neural tube like structures (arrows, F) formed after 14 days of
tered neural precursor cells (arrows, H) were also identiﬁed after 22 days of RA induction.
ected to IB for indicated proteins.β-actinwasused as a loading control.Medium containing
the 29-day RA induction. K and L, quantitative analysis of relative expression of OCT4 and
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differentiation.
3.2. DPF2 interacts with OCT4 in vitro and in vivo
We next want to examine if DPF2 co-localizes with OCT4 in H9 cells.
MG132 was also used in study of OCT4 protein subcellular distribution
[57]. Therefore, we performed IF assay for checking localization of DPF2
and OCT4 in the presence of MG132. Undifferentiated H9 cells main-
tained in mTeSR medium supplemented with 20 μm MG132 were
ﬁxed and subjected to an IF assay. Colocalization of DPF2 (Fig. 2A, DFig. 2. Interaction between DPF2 and OCT4 in vivo and in vitro. A–E, H9 cells maintained onMat
E) and anti-OCT4 (B, D and E, green) antibodies. Nuclei were counterstained by DAPI (blue, C an
incubated with H9 cell lysates and precipitated by glutathione-Sepharose 4B beads, followed b
brane indicates expression of GST and GST-fusion proteins (lower panel). G–K, P19 cells mainta
(H, J and K, green) antibodies. Colocalization of OCT4 andDPF2was indicated by arrows (G, H, J
treatedwithMG132 for 6 h. Then the cells were harvested and the lysates were subjected to IP
used as a control. IgGH, IgG heavy chain.and E, red) and OCT4 (Fig. 2B, D and E, green) was found in nuclei of
H9 cells (Fig. 2D and E, arrows). Moreover, DPF2 and OCT4 co-localized
with some of the DNA signals that were shown by DAPI staining
(Fig. 2C and E, arrows). To examine the interaction between DPF2 and
OCT4 in vitro, we generated GST–DPF2 and GST–RNF2 fusion proteins
to be used in GST-pull down assays. Here, RNF2, an OCT4-interacting
RING ﬁnger E3, was used as a positive control [23,58]. Both GST–RNF2
and GST–DPF2 were found to copurify with OCT4, with GST–DPF2
interacting more efﬁciently with OCT4 (Fig. 2F).To further address en-
dogenous DPF2–OCT4 interaction in P19 cells, P19 cells were subjected
IF assay with anti-DPF2 and anti-OCT4 antibodies. Colocalization ofrigel coated coverslips were ﬁxed and subjected to IF assay using anti-DPF2 (red, A, D and
d E). Bar= 10 μm. F, GST, GST-tagged human recombinant DPF2 and RNF2 proteins were
y an IB assay with anti-OCT4 antibody (upper panel). Ponceau staining of the PVDF mem-
ined on coverslips were subject to IF assay using anti-DPF2 (G, J and K, red) and anti-OCT4
and K). Nuclei were counterstained byDAPI (blue, I and K). Bar= 10mm. L, P19 cells were
assay with anti-OCT4 antibody followed by IB for indicated proteins. IP assaywith IgG was
3284 C. Liu et al. / Biochimica et Biophysica Acta 1853 (2015) 3279–3293DPF2 (Fig. 2G, J and K, red) and OCT4 (Fig. 2H, J and K, green) was also
found in nuclei of P19 cells (Fig. 2J and K, arrows). However, compared
with thediffusive distribution ofDPF2 andOCT4 inH9 cell nuclei, a punc-
tate distribution pattern of DPF2 and OCT4 in P19 cells was identiﬁed.
Next, to prove DPF2–OCT4 interaction using biochemistry method,
P19 cells treated by MG132 for 6 h were harvested and subjected to IP
using control IgG and anti-OCT4 antibody, respectively, and followed
by IB for the indicated proteins. Results also showed that endogenous
DPF2 coprecipitated with OCT4 in P19 cells (Fig. 2L). We wonder if
DPF2 interacts with ectopic OCT4 in somatic cells. We use enhanced
green ﬂuorescent protein (EGFP) as a tag formonitoring intracellular lo-
calization of DPF2. Meanwhile, EGFPwas used as a negative control, and
EGFP-tagged RNF2, RNF2–EGFP, was used as a positive control. BothFig. 3. In vitroubiquitination ofOCT4 byDPF2. A,His-tagged humanOct4was expressed in Esche
were expressed in Escherichia coliBL-21 and immobilized on glutathione-Sepharose beads. GST–
OCT4 and subjected to IBwith anti-OCT4 antibody. Ponceau staining of the PVDFmembrane ind
was immunopuriﬁed fromH9 cell lysates. The anti-OCT4 antibody conjugated protein Gwas us
for 2 h throughuse of RRL and recombinantGSTorGST-tagged humanDPF2. Then the products o
PAGE, and immunoblotted with anti-OCT4 (top panel), anti-Ub (middle pannel) and then withDPF2–EGFP and RNF2–EGFP expressed mainly in nuclei of 293 cells
(Fig. S2A–I). When coexpressed with OCT4, both DPF2–EGFP and
RNF2–EGFP showed a colocalization with ectopic OCT4 in double-
positive 293 cell nuclei (Fig. S2J–Q, arrows).
These results suggest that DPF2 may serve as an OCT4-associated
protein.
3.3. In vitro ubiquitination of OCT4 by DPF2
To demonstrate DPF2 interacts with OCT4 directly, we performed
GST-pull down assay using recombinant GST-tagged human DPF2 as a
bait protein, His-tagged humanOCT4 as a source of prey protein, and re-
combinant GST as a control. GST–DPF2 but not GST was capable ofrichia coli BL-21 and puriﬁedusingNi-NTA agarose. Glutathione S-transferase (GST) fusions
DPF2 immobilized on glutathione-Sepharose beadswere incubatedwith recombinantHis-
icates expression of GST and GST–DPF2. B and C, Protein G-Sepharose-bound OCT4 protein
ed as a control. The immunoprecipitates were subjected to in vitro ubiquitination reactions
f the in vitro ubiquitination assaywere elutedwith SDS-sample buffer, resolved by8% SDS-
anti-GST (bottom panel) antibodies.
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directly in vitro. We next performed in vitro ubiquitination assay using
rabbit reticulocyte lysate (RRL) as a source of E1 and E2 and anti-OCT4
immunoprecipitates obtained from H9 cell lysates as substrates. The
anti-OCT4 antibody conjugated protein G was incubated with or with-
out H9 cell lysates over night at 4 °C and was subjected to following
in vitro ubiquitination assay. No ubiquitinated OCT4 was detected
(Fig. 3B, top panel, lane 1–3)without the presence of OCT4 precipitates.
When compared to GST (Fig. 3B, bottom panel, lane 1), GST–DPF2
formed more ubiquitinated DPF2 species that were recognized by
both anti-Ub (Fig. 3B, middle panel, lane 2) and anti-GST (Fig. 3B,
bottom panel, lane 2) antibodies. However, ubiquitinated GST-DPF2
was almost lost in the absence of RRL(Fig. 3B, lane 3).With the presence
of OCT4 precipitates, more ubiquitinated OCT4 species, whichwere rec-
ognized by both anti-OCT4 (Fig. 3C, top panel, lane 2) and anti-Ub
(Fig. 3C, middle panel, lane 2) antibodies, were induced by GST–DPF2
as compared to GST (Fig. 3C, bottom panel, lane 1).
These results suggest that DPF2 might act as an E3 ligase for OCT4.
3.4. Upregulation of OCT4 by dpf2/DPF2 siRNA affects RA induced H9 cell
differentiation
Currently, role of DPF2–OCT4 interaction in cell biology is not clear.
Therefore, we examined effect of DPF2-knockdown on OCT4 expression
in P19 cells and H9 cells, respectively, using dpf2/DPF2 siRNAs (Fig. 4).
The effect of dpf2 siRNAs on DPF2 expression was checked ﬁrst in P19
cells. As expected, negative control (nc) siRNA failed to affect DPF2
expression, while positive control, gapdh siRNA, decreased GAPDH
expression signiﬁcantly. The dpf2 siRNAs showed signiﬁcant effects on
DPF2 expression (Fig. 4A). In P19 cells, #370 dpf2 siRNA was found
more efﬁcient as compared to the other dpf2 siRNAs. Moreover, dpf2
siRNA increased expression of OCT4 when compared with nc and
gapdh siRNAs (Fig. 4A). CHX chase time assay was performed at indicat-
ed time points using P19 cells transfected by oligonucleotides of nc,
gapdh and #370 dpf2 siRNAs, respectively. IB assay result showed that
#370 dpf2 siRNA increased stability of OCT4 (Fig. 4B). Quantitative
analysis of the data suggests a signiﬁcant increase of OCT4 stability by
#370 dpf2 siRNA as compared to nc and gapdh siRNAs (Fig. 4C).
For H9 cells, stable lines of H9 cells infected by lentiviruses contain-
ing oligonucleotides of human DPF2 siRNAs (#25,540, #25,541 and
#25,542) were generated (Fig. 4D). The lentiviruses carrying #25,540
DPF2 siRNA led to a signiﬁcant silence of DPF2 gene as compared to
the otherDPF2 siRNAs (Fig. 4E, lane 2). By cytoplasmic and nuclear frac-
tion assay, we found thatDPF2 siRNA induces up-regulation of OCT4 but
not NANOG in both cytoplasm and nuclei, with nuclear OCT4 increased
more efﬁciently (Fig. 4F, lane 3 and 4). Especially, while expression
of OCT4 was upregulated together with DPF2 down-regulation sig-
niﬁcantly, NANOG level is reduced in knockdown cells, suggesting a
speciﬁc up-regulation of OCT4 by DPF2 siRNA (Fig. 4E and F). It is cur-
rently unknown whether down-regulation of OCT4 by DPF2 is
involved in hESC differentiation. We thus performed RA-induced dif-
ferentiation of H9 cells infected transiently by lentiviruses contain-
ing control siRNA and different doses (2 μl and 10 μl) of DPF2
siRNA. Results of IB assay proved knockdown of DPF2 by transient
expression of #25540 DPF2 siRNA, which shows a well dose-effect
relationship (Fig. 4G, middle panel, lane 4–6 and lane 7–9). Interest-
ingly, RA treatment downregulated OCT4 in the cells treated by the
control siRNA (Fig. 4G, top panel, lane 1–3) but not the DPF2 siRNA
(Fig. 4G, top panel, lane 4–6 and lane 7–9).
These results suggest that DPF2 may regulate OCT4 protein level
in vivo, which is involved in RA induced H9 cell differentiation.
3.5. Ubiquitination of ectopic OCT4 by overexpressed DPF2
It has been reported that ubiquitin proteasome system plays role in
degradation of OCT4 [24,25]. Previously, we also found ubiquitinatedOCT4 species, especially high-molecular-weight ubiquitinated OCT4
species, in H9 cells by denature-IP using anti-OCT4 antibody (see Fig.
1, in ref. [59]). To determine whether DPF2 plays role in OCT4
ubiquitination, 293 cells were cotransfected with EGFP, DPF2–EGFP
plasmids along with OCT4 plasmids. At 18 h after the transfection, the
cells were treated with 20 μM MG132 for 6 h, followed by IP with an
anti-OCT4 antibody. Results of IB assay showed that ubiquitinated
OCT4 species were recognized by both anti-Ub and anti-OCT4 antibod-
ies, and DPF2–EGFP (Fig. 5A and B, lane 4) induced more poly-
ubiquitinated OCT4 species than EGFP (Fig. 5A and B, lane 3). Moreover,
DPF2–EGFP but not EGFP precipitated with OCT4, suggesting DPF2 in-
teracts with OCT4 in the 293 cells (Fig. 5C), which is consistent with
the colocalization of DPF2–EGFP and OCT4 in Fig. S2J–M.
Because DPF2–EGFP is a C-terminal fusion protein, in which EGFP-
tag has amolecularweight of ~30KDa andmight interfere normal local-
ization of DPF2.We thus constructed a plasmid encoding an N-terminal
fusion protein of DPF2, FLAG–DPF2, for investigating role of DPF2 in
OCT4 ubiquitination. We cotransfected 293 cells with wild type FLAG–
DPF2, FLAG–DPF2 (WT) plasmid, along with OCT4 plasmid with
(Fig. 5E) or without (Fig. 5D) the presence of HA–Ub plasmid. At 18 h
after the transfection, the cells were treated with MG132 for 6 h and
subjected to IP using anti-OCT4 or anti-FLAG antibodies. The results of
following IB assay indicated that FLAG–DPF2 precipitated with OCT4
(Fig. 5D and E, upper panels, lane 4) and OCT4 precipitated with
FLAG–DPF2 (Fig. 5F, lower panel, lane 4).To exclude non-speciﬁc bind-
ing of OCT4 with FLAG antibody, HeLa cells were cotransfected with
plasmids encoding OCT4 and FLAG–DPF2. Then the cells were subjected
to IF assay with indicated antibodies (Fig. 5G, a–d). While the cells dou-
ble positive for OCT4 and FLAG–DPF2 were shown (Fig. 5G, a–d, ar-
rows), cells positive only for OCT4 were also detected (Fig. 5G, a–d,
arrowheads), which suggests that OCT4 does not bind FLAG antibody.
Further IF assay in 293 cells coexpressed DPF2–EGFP and OCT4 also
revealed cells double positive for EGFP and OCT4 (Fig. 5H–J, arrows)
and a cells positive only for EGFP (Fig. 5H–J, arrowheads), suggesting
DPF2–EGFP does not bind to OCT4. Finally, FLAG–DPF2 increased
ubiquitination of OCT4 (Fig. 5D and E, lower panels, lane 4), as com-
pared to FLAG–Vector (Fig. 5D and E, lower panels, lane 3). To examine
if OCT4 is indeed ubiquitinated, HeLa cells cotransfected with plasmids
encoding FLAG–DPF2 (WT) and OCT4 along with HA–Ub were subject-
ed to IF assaywith indicated antibodies.Well colocalization of OCT4 and
HA–Ub was detected in aggregate-like structures (Fig. 5K–M, arrows),
suggesting that ectopic OCT4 is modiﬁed by HA–Ub in 293 cells. These
results suggest that overexpression of DPF2 interacts with and
promotes ubiquitination of ectopic OCT4 in 293 cells.
3.6. PHD2 ﬁnger-dependent ubiquitination and degradation of ectopic
OCT4 by DPF2
DPF2has double PHDﬁngers in its C-terminal (Fig. 6A). Because PHD
ﬁnger has E3 activity that plays role in ubiquitination of substrate pro-
teins, we therefore want to investigate if ubiquitination of OCT4 by
DPF2 is related to the PHD ﬁngers. We ﬁrst made a homology analysis
for PHD ﬁngers from DPF2 and other proteins showing E3 activity
(Fig. 6B). For DPF2, while PHD1 has a homology score of 28%, PHD2
has a score of 39% (Fig. 6C). We next focused on possible role of PHD2
in OCT4 ubiquitination. We constructed a plasmid encoding mutant
form of DPF2, FLAG–DPF2 (M), in which the structure of PHD2 was
disrupted by mutation in the Histidine 353 and Cysteine 356 of the
C4HC3 consensus (Fig. 6D).
To directly assess the effect of PHD2 on OCT4 degradation, we
cotransfected 293 cells with FLAG–Vector(V), FLAG–DPF2 (WT) and
FLAG–DPF2 (M) plasmids along with OCT4 plasmid in 293 cells. Cells
were subject to CHX chase at 24 h after the transfection. Wild-type,
but not PHD2 mutant form of DPF2 enhanced OCT4 degradation
(Fig. 6E and F). As anE3, DPF2 likely facilitates OCT4 degradation bypro-
moting its ubiquitination,whichdepends on thePHD2domain.Wenext
Fig. 4. Upregulation of OCT4 protein level by DPF2 siRNA affects H9 differentiation induced by RA. A, IB assay for indicated proteins using P19 cells transfected by oligonucleotides of nc,
gapdh and dpf2 siRNAs (#237, #370 and #525), respectively. nc, negative control. B, Cyclohexmide chase time assay was performed at indicated time points using P19 cells transfected by
oligonucleotides of nc gapdh and #370 dpf2 siRNAs, respectively. IB assaywas performed for indicated proteins. C, quantitative analysis of data of chase time assay. *, P b 0.05 compared to
nc and gapdh siRNA, by independent sample T-test using SPSS17.0 software. Error bars represent standard error of three-independent experiments. D, phase andﬂuorescencemicrographs
ofH9 stable cell lines infected by lentiviruses containingDPF2 siRNAs (#25540, #25541 and #255421). E, H9 cells andH9 stable cell lineswith DPF2 knockdownwere subjected to IB assay
for indicated proteins. F, H9 cells and #25540H9 stable cell linewere subject to cytoplasmic (C) and nuclear (N) fraction assay, followed by IB for indicated proteins. G, H9 cells infected by
lentiviruses containing DPF2 siRNA #25540 were subjected to RA induced differentiation for 0, 1, 3 days and harvested at the different time points for following IB assay with indicated
antibodies. A lentivirus-based non-targeting siRNA was used as a control. H, Statistic data for OCT4 levels at the different time points of the RA induced H9 differentiation. *, P b 0.05,
by one way Anova using SPSS 17.0 software. Error bars represent standard error.
3286 C. Liu et al. / Biochimica et Biophysica Acta 1853 (2015) 3279–3293cotransfected 293 cells with FLAG–Vector (V), FLAG–DPF2 (WT) and
FLAG–DPF2 (M) plasmids along with OCT4 plasmid in the presence of
HA–Ub plasmid for 18 h. Then the cells were treated with MG132 for6 h and subjected to denatured IP using an anti-OCT4 antibody. The fol-
lowing IB indicated that the denatured IP disrupted the interaction be-
tween OCT4 and DPF2 but did not affect the covalent conjugation
Fig. 5.Overexpression ofDPF2 ubiquitinates ectopicOCT4 in293 cells. A–C, 293 cellswere transfectedwith EGFP–Vector, DPF2–EGFP alongwithOCT4.With thepresence ofMG132 for 6 h,
cells were harvested and subject to IP assay with anti-OCT4 antibody followed by IB for Ub (A), OCT4 (B) and EGFP (C). IgGH, IgG heavy chain. IgGL, IgG light chain. D–F, 293 cells were
transfected with FLAG–Vector, FLAG–DPF2 alongwith OCT4with (E) or without (D) HA–Ub plasmids for 18 h.With the presence of MG132 for 6 h, cells were harvested and subject to IP
assay with an anti-OCT4 antibody (D and E) and an anti-FLAG antibody (F), respectively, followed by IB for the indicated proteins. G, HeLa cells transfected by FLAG–DPF2 and OCT4 plas-
mids were subjected to IF assay with anti-OCT4 (a and d, green) and a Cy3-conjugated anti-FLAG antibodies (b and d, red). The nuclei were counterstained by DAPI. Bar= 5 μm. H–J, 293
cells transfected by DPF2–EGFP and OCT4 plasmids were subjected to ﬂuorescence assay (H and J, green) and IF assay with anti-OCT4 antibody (I and I, red). The nuclei were counter-
stained by DAPI. Bar = 5 μm. K–M, HeLa cells transfected by FLAG–DPF2 and OCT4 along with HA–Ub plasmids were subjected to IF assay with anti-HA (K and M, red) and anti-OCT4
antibodies (L and M, green). The nuclei were counterstained by DAPI. Bar = 5 μm.
3287C. Liu et al. / Biochimica et Biophysica Acta 1853 (2015) 3279–3293between Ub and OCT4 (Fig. 6G–H). Wild-type (Fig. 6H, lane 2), but not
the PHD2 mutant (Fig. 6H, lane 3) form of DPF2 increased OCT4
ubiquitination. We also cotranfected 293 cells with FLAG–DPF2(WT)andFLAG–DPF2(M) along with OCT4 plasmids. IP assay in native condition
using anti-OCT4 anti-body followed by IB with indicated antibodies was
performed. The results showed that both wild type and PHD2 mutant
Fig. 6. The second PHD ﬁnger of DPF2 is involved in ubiquitination and degradation of OCT4. A, Schematic representation of domainswithin DPF2 (391 amino acids). A ZnF C2H2 domain,
PHD1 (272–328) and PHD2 (279–375) ﬁngers are shown. B, The PHD1 and PHD2domains of DPF2 showhomologywith the PHDdomains fromother proteins showing E3 ubiquitin ligase
activity. The Uniprot/Ensembl sequence identiﬁer (ID)/accession number (ACC) of each protein is shown. C, homology tree and scores of PHD domains from DPF2 and other proteins
showing E3 ubiquitinligase activity. D, Schematic representation of wild type (WT) PHD2 ﬁnger of human DPF2 and mutation (M) in PHD2 ﬁnger. E, 293 cells were transfected with
FLAG–Vector (V), FLAG–DPF2 (WT) and FLAG–DPF2 (M) along with OCT4. A chase time assay was performed and cells were then harvested and lysed in NP-40 lysis buffer followed
by SDS-PAGE and IB. F, data from 4 independent experiments were quantiﬁed based on the density of OCT4 bands. *, P b 0.05 compared to the vector and mutant DPF2, by independent
sample T-test using SPSS 17.0 software. Error bars represent standard error. CHX, cycloheximide. G and H, 293 cells were transfected with FLAG–Vector (V), FLAG–DPF2 (WT) and
FLAG–DPF2 (M) along with OCT4. Then the cells were subjected to denature-IP assay with anti-OCT4 antibody followed by IB for indicated proteins. D-IP, IP under denaturing conditions.
H.M.W, high molecular weight.
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3289C. Liu et al. / Biochimica et Biophysica Acta 1853 (2015) 3279–3293DPF2 interact with OCT4. PHD2 mutant DPF2 decreased the OCT4
ubiquitination induced by wild type DPF2 (Fig. S3).
These results suggest that DPF2 contributes to ubiquitination and
degradation of OCT4 in a PHD2-dependent manner.Fig. 7. K48-linked ubiquitination of OCT4 by DPF2. A, 293 cells were transfected with OCT4 and
(WT). At 18–20 h after transfection, cells were exposed to 20 μMMG132 for 6 h. Cells were the
indicated proteins. B and C, quantiﬁcation of OCT4 andOCT4–6His–Ub species aswell as total 6H
OCT4 (ΔOCT4) and OCT4–6His–Ub (ΔOCT4–6His–Ub) as well as 6His–Ub species (Δ6His–Ub) i
and 6His–Ub species from 8 lanes. **, P b 0.01, by independent sample T-test using SPSS 17.0 s3.7. DPF2 assembles mainly K48-linked ubiquitination of OCT4
The K linkage of Ub determines substrate fate [18]. Therefore, we
examined which K residue (or residues) in the Ub molecule might beone of the 6His-tagged mutant Ubs, as indicated, and either with or without FLAG–DPF2
n lysed and the lysates were subjected to IP with an OCT4 antibody followed by IB for the
is–Ub species coprecipitatedwith OCT4 for each lane in Fig. 6A. D, change in the density of
n each lanewas calculated and shown. E, statistic data for the average unit of OCT4 species
oftware. Error bars represent standard error.
3290 C. Liu et al. / Biochimica et Biophysica Acta 1853 (2015) 3279–3293involved in the induction of poly-ubiquitin chains onOCT4 byDPF2. 293
cells were transfected with plasmids encoding OCT4 and a His-tagged
Ubmutantwithout Ks (K0), or Ubmutantswith a single K,with orwith-
out the presence of FLAG–DPF2 plasmids. Transfected cells were har-
vested and subjected to IP with an anti-OCT4 antibody, followed by IB
for the indicated proteins. Bands representing mono-ubiquitinated
OCT4 or OCT4–6His–Ubwere detected (Fig. 7A, middle panels). Quanti-
ﬁcation of OCT4 species, including monomeric OCT4, OCT4–6His–Ub,
and total 6His–Ub species coprecipitated with OCT4, was performed ac-
cording to the density of related bands in Fig. 7A (Fig. 7B and C). The
density change of the OCT4 species and 6His–Ub species, with
(DPF2+)orwithout (DPF2−) DPF2,was calculated and shown, respec-
tively (Fig. 7D and E).
Results indicated that poly-ubiquitinated OCT4was detected even in
the absence of DPF2, possibly generated by endogenous E3s for OCT4
(Fig. 7A, left panels). The expression of DPF2 enhanced the poly-
ubiquitination of OCT4 in the presence of Ub–K6, Ub–K48 and
Ub–K63, but not Ub–K0, Ub–K11, Ub–K27 and Ub–K29, suggesting
that DPF2 may preferentially assemble poly-ubiquitin chains on OCT4
through K6, K48 and K63 linkages, of which K48 linkage is more efﬁ-
cient (Fig. 7A, right panels, lane 2, 7 and 8; Fig. 7B and D). Notably,
while levels of monomeric OCT4 were down-regulated in the presence
of Ub–K6 and Ub–K48 by DPF2, level of monomeric OCT4 in the
presence of Ub–K63was almost not changed (Fig. 7C). Actually, the aver-
age levels of OCT4 and mono-ubiquitinated OCT4 were down-regulated
signiﬁcantly (Fig. 7E). These results suggest that ubiquitination and
degradation of OCT4 by DPF2 mainly depends on Ub–K48 residue.
3.8. Nuclear distribution of ectopic DPF2 and OCT4
Although OCT4 is expressed mainly in ESCs, subcellular localization
of OCT4 has been studied using HeLa cell by several groups [16,17,57].
In our study, expression of ectopic OCT4 alone in HeLa cells resulted in
diffusive distribution in nuclei (Fig. 8A–D). However, coexpression of
FLAG–DPF2 (WT) and OCT4 formed a non-diffusive structure (Fig. 8E–
H), in which DPF2 and OCT4 colocalized well, and also with DNA, as re-
vealed by DAPI staining (Fig. 8E–H, arrows). Data employed more cells
showed that while OCT4 alone was diffusive in nuclei (Fig. S4, A2, B2
and D2, arrowheads), OCT4was non-diffusive in nuclei coexpressed ro-
bust DPF2 and OCT4 (Fig. S4, A1, B1 and D1, arrows). Moreover, with
(Fig. 8E–H) or without (Fig. 8A–D) the presence of wild type DPF2, dis-
tribution of DAPI signals were similar with that of OCT4, which can also
be identiﬁed in Fig. S4 (E–H and I–L, triangles).
We next asked whether the PHD2 of DPF2 is involved in regulating
OCT4 sub-nuclear distribution.We transfected HeLa cells with plasmids
encoding FLAG–DPF2 (M) (Fig. 8I and L, red) along with OCT4 plasmid
(Fig. 8J and L, green). IF assay revealed that DPF2 (M) and OCT4 co-
aggregates in nuclei (Fig. 8I, J and L, arrows). However, the aggregates
are negative for DAPI staining (Fig. 8I, J and L, arrowheads). Data
employedmore cells showed thatwhileOCT4 alone is diffusive in nuclei
(Fig. S5, A2, B2 and D2, arrowheads), some of OCT4 signals co-
aggregated with mutant DPF2 in nuclei double positive for mutant
DPF2 and OCT4 (Fig. S5, A1, B1 and D1, arrows). Moreover, distribution
of DNA signals in nuclei only positive for OCT4was different with that of
nuclei double positive for mutant DPF2 and OCT4 (Fig. S5, E–H, arrows).
Through IP analysis, OCT4 coprecipitated with DPF2 (WT) and DPF2
(M) (Fig. 8M), suggesting the PHD2 mutation does not affect DPF2–Fig. 8. Overexpression of DPF2 redistributes ectopic OCT4 in HeLa cells. A–H, HeLa cells grew o
OCT4 plasmids. After 18 h, cellswereﬁxed and subjected to IF assay for OCT4 (B, D, F andH, gree
5 μm. I–L, HeLa cells grew on coverslips were cotransfected with FLAG–DPF2 (M) and OCT4 pl
green) and DPF2 (I and L, red). Nuclei were counterstained by DAPI (J and L, blue). Bar = 5 μm
(M) alongwith OCT4 plasmids for 18 h. After treatmentwithMG132 for 6 h, cellswere lysed and
proteins. N, schematic representation of DPF2 regulatesOCT4 protein level and nuclear distribut
radation of OCT4. Ubiquitination of OCT4 might bemainly through Ub–K48 linkage. Mutation i
crease DNA binding, ubiquitination and degradation of OCT4.OCT4 interaction. The schematic representation of DPF2 regulates
OCT4 protein level and nuclear distribution is shown (Fig. 8N).
4. Discussion
In this study, we made several important novel observations:
1) DPF2 up-regulation is accompanied byOCT4 down-regulation during
RA-inducedH9 cell differentiation. 2)DPF2 interactswithOCT4 and acts
as anE3 ligase. 3)dpf2/DPF2 siRNAs increasedOCT4 protein level in both
P19 cells and H9 cells. 4) RA fails to downregulate OCT4 protein level in
DPF2-knockdown H9 cells. 5) Overexpression of DPF2 changes the
sub-nuclear localization of OCT4 and promotes ubiquitination and
degradation of OCT4 in a PHD2-dependent manner. 6) Ubiquitination
and degradation of OCT4 by DPF2 mainly depends on Ub–K48 residue.
At the beginning, we found that differentiated H9 cells expressed
more DPF2 and that OCT4 down-regulation is accompanied by signiﬁ-
cant DPF2 up-regulation, not at the early stage but instead at a later
stage in H9 cell differentiation induced by RA. In contrast, WWP2, an
E3 that promotes OCT4 degradation in undifferentiated human ESCs,
is quickly down-regulated after human ESC differentiation [24]. The pri-
mary role for WWP2 is assumed to be to regulate pluripotency rather
than manipulate differentiation [60]. According to our data, DPF2
shRNA affects RA induced H9 cell differentiation and DPF2 catalyses
ubiquitination and degradation of OCT4, implying that DPF2 might
down-regulate OCT4 protein level through ubiquitination in hESC dif-
ferentiation. Therefore, continued up-regulation of DPF2 during the
prolonged differentiation period suggests that DPF2 may be involved
in sustaining human ESC differentiation after the initiation of differenti-
ation as a result of developmental or environmental signalling. This
hypothesis is also supported by our ﬁnding that 293 cells and HeLa
cells expressed higher levels of DPF2 than H9 cells.
Themaintenance of stem cell self-renewal requires a precise level of
OCT4 [4]. OCT4 manipulated above and below endogenous levels in
human ESCs leads to divergent cell types [61]. Therefore, knockdown
of DPF2 may induce differentiation of human ESCs through increasing
OCT4 level. Interestingly, DPF2 siRNA upregulates endogenous OCT4
level in H9 cells, but fails to increase protein level of NANOG, another
pluripotentmarker protein. It has been reported that NANOG is less sta-
ble than OCT4 and degradation of OCT4 is different from that of NANOG
in stem cells [62]. Our ﬁnding here might also suggest the different sta-
bilities between OCT4 and NANOG in human ESCs. These results imply
that DPF2may be a potential target for regulatingOCT4 level and further
ESC differentiation. OCT4 levels are also associated with tumour pro-
gression or bad diagnosis [63]. Overexpression of OCT4 enhanced
whereas knockdown of OCT4 reduced liver cancer cell resistance to che-
motherapeutic drugs [64]. DPF2 decreased the level of monomeric and
monoubiquitinated OCT4 but increased poly-ubiquitination of OCT4.
Mono-ubiquitination of OCT4 inhibits OCT4 transcription activity rather
than targeting theprotein for degradation [25]. DPF2may regulate OCT4
activity through proteolytic and non-proteolytic pathways by regulat-
ing OCT4 mono-ubiquitination and/or poly-ubiquitination. Moreover,
in vitro ubiquitnation assay indicates that DPF2 promotes OCT4
ubiquitnation. Thus, DPF2 might serve as a potential E3 that regulates
OCT4 levels and function. How, when and where different OCT4
ubiquitination modiﬁcations and the resulting functional alterations
are initiated warrants rigorous investigation in our future studies.
PHD2 mutation of DPF2 forms aggregate-like structures with whichn coverslips were transfected with FLAG–Vector (A–D) and FLAG–DPF2 (E–H) along with
n) andDPF2 (E andH, red). Nucleiwere counterstained byDAPI (C, D, G andH, blue). Bar=
asmids. After 18 h, cells were ﬁxed and subjected to ﬂuorescence assay for OCT4 (J and L,
. M, 293 cells were transfected with FLAG–Vector (V), FLAG–DPF2 (WT) and FLAG–DPF2
lysateswere subjected to IP assaywith an anti-OCT4 antibody followed by IB for indicated
ion. DPF2–OCT4 interactionmight play role in OCT4–DNAbinding, ubiquitination and deg-
n PHD2 ﬁnger of DPF2 induces co-aggregation of mutant DPF2 and OCT4, whichmight de-
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ubiquitination of OCT4 by not only DPF2 but also other E3s ligases.
Thus, overexpressed PHD2 mutant DPF2 could be a dominant negative
form of DPF2, which might inhibit endogenous ubiquitination of OCT4.
For detecting ubiquitination of OCT4, MG132 treatment had been re-
ported in several papers [24,25,65]. Interestingly, wwp2, a HECT-type
E3 ubiquitin ligase, regulates ubiquitination and degradation of not
only OCT4 but also itself [66]. We thus speculate proteasome inhibition
mediated byMG132maymake it more promising for us to detect inter-
action proteins of OCT4 during CoIP and/or IP assays. The hypothesis is
proved by our new ﬁnding that DPF2 is ubiquitinated in vitro (Fig. 3B)
and its level is upregulated by MG132 in nuclei (see Fig. 3 in [59]). Pre-
viously, MG132 treatment increased OCT4 expression in undifferentiat-
ed cells [62,67]. Actually, the treatment ofMG132was performed for no
more than 6 h just before harvesting the cells. SinceMG132 can prevent
degradation of a lot of proteins of which their levels are manipulated by
UPS, including proteins involved in both pluripotency and differentia-
tion [22], it thus might be complex to examine if the treatment of
MG132 for only 6 h could prevent OCT4 reduction during induced differen-
tiation. The beneﬁt of MG132 treatment is to avoid protein degradation
and get more proteins as possible as for following studies, in case some
important proteins are degraded by UPS.
DPF2 assembled poly-ubiquitin chains on OCT4 through K6, K48 and
K63 linkages, with K48-linkage is more efﬁcient. K6-linked OCT4
ubiquitinationwas clearly identiﬁed by both anti-His and anti-OCT4 an-
tibodies. However, K48 andK63-linkedOCT4 ubiquitinationwas detect-
edmainly using an anti-His antibody. Using an anti-OCT4 antibody, only
high molecular weight bands were detected for the K48 linkage, sug-
gesting DPF2 may generate mainly poly-ubiquitinated OCT4 speices
with high molecular weight. Because different Ub lysine linkages may
lead to different conformations of ubiquitinated substrates [68], we can-
not exclude the possibility that these antibodies may not recognize the
K48-linked ubiquitinated OCT4 species well. Notably, RNF2, a RING ﬁn-
ger E3 that interacts with OCT4 and functions in maintaining stem cell
pluripotency [23], also generates atypical mixed K6, K27 and K48
poly-ubiquitin linkages [69]. Another OCT4-interacting E3, WWP2, as-
sembles K63 poly-ubiquitin linkage of OCT4 [24]. Hence, OCT4
ubiquitination via different lysine linkages is involved in regulating
OCT4 function. Ubiquitination of a substrate via different lysines gov-
erns a variety of biological processes [68]. K48-linked ubiquitination tar-
gets a substrate protein for proteasomal degradation [70], whereas K63-
linked ubiquitination contributes to the formation of protein aggregates
[71]. Although K6-linked ubiquitination has a nonproteolytic effect on
its target proteins [69], it also targets substrates for proteasomal degra-
dation [72]. Actually, among all of the poly-ubiquitinated OCT4 induced
by DPF2, more than a half was formed through Ub–K48 linkage,
supporting our observation that proteasome inhibition increased OCT4
ubiquitination and DPF2 facilitated OCT4 degradation. However,
the function of K6 and K63-linked ubiquitinated OCT4 remain to be
elucidated.
As we know, OCT4 plays role in maintaining self renewal and
pluripotency in ESCs. OCT4 also plays role in somatic cell reprogramming.
Besides, OCT4 is involved in cancer development as a result of insufﬁcient
reprogramming [73] Therefore, understanding sub-cellular localization of
OCT4 in both somatic cells and pluripotent stem cells is important.
MG132 downregulated cytoplasmic DPF2 and induced accumulation of
DPF2 in nuclei, in which OCT4 colocalized with accumulated DPF2(see
Fig. 3 in ref. [59]). Because the right localization of OCT4 is required for
its function in somatic cell reprogramming and ESC self renewal [16],
the altered nuclear distribution of OCT4 by DPF2 in HeLa cells and H9
cells may more or less suggest a signiﬁcance for reprogramming somatic
cells into iPSCs and further, maintenance of self renewal of iPSCs. Regula-
tion of OCT4 subnuclear distribution appears to require an intact PHD2 in
DPF2. The PHD mutant form of DPF2, DPF2 (M), failed to redistribute
OCT4, but retained its ability to interact with OCT4, leading to
coaggregation of DPF2 (M) and OCT4 in the nuclei. Importantly, theDPF2 (M) and OCT4 aggregates are devoid of DNA, suggesting that the
PHD may be required for DPF2 regulating OCT4 and DNA binding.
In ESCs, DNA binding is required for OCT4 to associate with various
promoter regions and to repress the transcription of various genes in
one context while activate in another [1,74]. Another form of posttrans-
lational modiﬁcation, small ubiquitin-related modiﬁer (SUMO) modiﬁ-
cation (sumoylation), was reported to enhance OCT4-DNA binding
[75]. Whether ubiquitination of OCT4 might play a role in OCT4-DNA
binding remains to be determined in our future studies.
Collectively, our ﬁndings presented here may expand an under-
standing of howOCT4 protein level and nuclear distribution is regulated
and provide a potential target for manipulating OCT4 protein level.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2015.09.029.
Conﬂict of interest statement
Here all authors disclose no conﬂict of interest.
Acknowledgements
This project was sponsored by a grant from the National Natural
Science Foundation of China (31271159), a Maryland TEDCO grant
(2007-MSCRFE-0139-01), a Technology Foundation for Selected
Overseas Chinese Scholar Grant (2012 No. 13) from Anhui HRSS, a
grant for scientiﬁc research of BSKY (XJ201105) from Anhui Medical
University. We thank the help from Central Laboratory of Molecular
and Cellular Biology, School of Basic Medical Sciences, Anhui Medical
University. We thank Dr. Yun Qiu and Dr. Yihong Ye for providing
plasmids.
References
[1] L.A. Boyer, T.I. Lee, M.F. Cole, S.E. Johnstone, S.S. Levine, J.P. Zucker, M.G. Guenther,
R.M. Kumar, H.L. Murray, R.G. Jenner, D.K. Gifford, D.A. Melton, R. Jaenisch, R.A.
Young, Core transcriptional regulatory circuitry in human embryonic stem cells,
Cell 122 (2005) 947–956.
[2] Y. Babaie, R. Herwig, B. Greber, T.C. Brink,W.Wruck, D. Groth, H. Lehrach, T. Burdon, J.
Adjaye, Analysis of Oct4-dependent transcriptional networks regulating self-renewal
and pluripotency in human embryonic stem cells, Stem Cells 25 (2007) 500–510.
[3] M. Zuccotti, V. Merico, M. Bellone, F. Mulas, L. Sacchi, P. Rebuzzini, A. Prigione, C.A.
Redi, R. Bellazzi, J. Adjaye, S. Garagna, Gatekeeper of pluripotency: a common Oct4
transcriptional network operates in mouse eggs and embryonic stem cells, BMC Ge-
nomics 12 (2011) 1–13.
[4] H. Niwa, J. Miyazaki, A.G. Smith, Quantitative expression of Oct-3/4 deﬁnes differen-
tiation, dedifferentiation or self-renewal of ES cells, Nat. Genet. 24 (2000) 372–376.
[5] K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, S. Yamanaka,
Induction of pluripotent stem cells from adult human ﬁbroblasts by deﬁned factors,
Cell 131 (2007) 861–872.
[6] J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie,
G.A. Jonsdottir, V. Ruotti, R. Stewart, I.I. Slukvin, J.A. Thomson, Induced pluripotent
stem cell lines derived from human somatic cells, Science 318 (2007) 1917–1920.
[7] I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch,
G.Q. Daley, Reprogramming of human somatic cells to pluripotency with deﬁned
factors, Nature 451 (2008) 141–146.
[8] J.B. Kim, V. Sebastiano, G. Wu, M.J. Arauzo-Bravo, P. Sasse, L. Gentile, K. Ko, D. Ruau,
M. Ehrich, D. van den Boom, J. Meyer, K. Hubner, C. Bernemann, C. Ortmeier, M.
Zenke, B.K. Fleischmann, H. Zaehres, H.R. Scholer, Oct4-induced pluripotency in
adult neural stem cells, Cell 136 (2009) 411–419.
[9] Y. Li, Q. Zhang, X. Yin,W. Yang, Y. Du, P. Hou, J. Ge, C. Liu,W. Zhang, X. Zhang, Y.Wu,H.
Li, K. Liu, C.Wu, Z. Song, Y. Zhao, Y. Shi, H. Deng, Generation of iPSCs frommouseﬁbro-
blasts with a single gene, Oct4, and small molecules, Cell Res. 21 (2011) 196–204.
[10] Y.A. Tang, C.H. Chen, H.S. Sun, C.P. Cheng, V.S. Tseng, H.S. Hsu,W.C. Su,W.W. Lai, Y.C.
Wang, Global Oct4 target gene analysis reveals novel downstream PTEN and TNC
genes required for drug-resistance and metastasis in lung cancer, Nucleic Acids
Res. 43 (2015) 1593–1608.
[11] Y.D. Wang, N. Cai, X.L. Wu, H.Z. Cao, L.L. Xie, P.S. Zheng, OCT4 promotes tumorigen-
esis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway, Cell
Death Dis. 4 (2013), e760.
[12] Y. Lu, H. Zhu, H. Shan, J. Lu, X. Chang, X. Li, X. Fan, S. Zhu, Y.Wang, Q. Guo, L.Wang, Y.
Huang, M. Zhu, Z. Wang, Knockdown of Oct4 and Nanog expression inhibits the
stemness of pancreatic cancer cells, Cancer Lett. 340 (2013) 113–123.
[13] S.H. Chiou, M.L. Wang, Y.T. Chou, C.J. Chen, C.F. Hong, W.J. Hsieh, H.T. Chang, Y.S.
Chen, T.W. Lin, H.S. Hsu, C.W.Wu, Coexpression of Oct4 and Nanog enhancesmalig-
nancy in lung adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation, Cancer Res. 70 (2010) 10433–10444.
3293C. Liu et al. / Biochimica et Biophysica Acta 1853 (2015) 3279–3293[14] F.Y. Al-Marzoqee, G. Khoder, H. Al-Awadhi, R. John, A. Beg, A. Vincze, F. Branicki, S.M.
Karam, Upregulation and inhibition of the nuclear translocation of Oct4 during
multistep gastric carcinogenesis, Int. J. Oncol. 41 (2012) 1733–1743.
[15] G. Karoubi, L. Cortes-Dericks, M. Gugger, D. Galetta, L. Spaggiari, R.A. Schmid,
Atypical expression and distribution of embryonic stem cell marker, OCT4, in
human lung adenocarcinoma, J. Surg. Oncol. 102 (2010) 689–698.
[16] M. Oka, T. Moriyama, M. Asally, K. Kawakami, Y. Yoneda, Differential role for tran-
scription factor Oct4 nucleocytoplasmic dynamics in somatic cell reprogramming
and self-renewal of embryonic stem cells, J. Biol. Chem. 288 (2013) 15085–15097.
[17] G. Pan, B. Qin, N. Liu, H.R. Scholer, D. Pei, Identiﬁcation of a nuclear localization signal
in OCT4 and generation of a dominant negative mutant by its ablation, J. Biol. Chem.
279 (2004) 37013–37020.
[18] A.M. Weissman, Themes and variations on ubiquitylation, Nat. Rev. Mol. Cell Biol. 2
(2001) 169–178.
[19] R. Layﬁeld, J.R. Cavey, J. Lowe, Role of ubiquitin-mediated proteolysis in the
pathogenesis of neurodegenerative disorders, Ageing Res. Rev. 2 (2003) 343–356.
[20] A. Hershko, A. Ciechanover, The ubiquitin system, Annu. Rev. Biochem. 67 (1998)
425–479.
[21] J.S. Thrower, L. Hoffman, M. Rechsteiner, C.M. Pickart, Recognition of the
polyubiquitin proteolytic signal, EMBO J. 19 (2000) 94–102.
[22] C. Naujokat, T. Saric, Concise review: role and function of the ubiquitin-proteasome
system in mammalian stem and progenitor cells, Stem Cells 25 (2007) 2408–2418.
[23] M. Endoh, T.A. Endo, T. Endoh, Y. Fujimura, O. Ohara, T. Toyoda, A.P. Otte, M. Okano,
N. Brockdorff, M. Vidal, H. Koseki, Polycomb group proteins ring1a/B are functionally
linked to the core transcriptional regulatory circuitry to maintain ES cell identity,
Development 135 (2008) 1513–1524.
[24] H. Xu, W. Wang, C. Li, H. Yu, A. Yang, B. Wang, Y. Jin, WWP2 promotes degradation of
transcription factor OCT4 in human embryonic stem cells, Cell Res. 19 (2009) 561–573.
[25] H.M. Xu, B. Liao, Q.J. Zhang, B.B. Wang, H. Li, X.M. Zhong, H.Z. Sheng, Y.X. Zhao, Y.M.
Zhao, Y. Jin, Wwp2, an E3 ubiquitin ligase that targets transcription factor Oct-4 for
ubiquitination, J. Biol. Chem. 279 (2004) 23495–23503.
[26] T. Geetha, R.S. Kenchappa, M.W. Wooten, B.D. Carter, TRAF6-mediated
ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor,
EMBO J. 24 (2005) 3859–3868.
[27] J.P. Kruse, W. Gu, MSL2 promotes Mdm2-independent cytoplasmic localization of
p53, J. Biol. Chem. 284 (2009) 3250–3263.
[28] M.B. Metzger, V.A. Hristova, A.M. Weissman, HECT and RING ﬁnger families of E3
ubiquitin ligases at a glance, J. Cell Sci. 125 (2012) 531–537.
[29] M. Scheffner, S. Kumar, Mammalian HECT ubiquitin-protein ligases: biological and
pathophysiological aspects, Biochim. Biophys. Acta 1843 (2014) 61–74.
[30] M. Pardo, B. Lang, L. Yu, H. Prosser, A. Bradley, M.M. Babu, J. Choudhary, An expand-
ed Oct4 interaction network: implications for stem cell biology, development, and
disease, Cell Stem Cell 6 (2010) 382–395.
[31] J.Wang, S. Rao, J. Chu, X. Shen, D.N. Levasseur, T.W. Theunissen, S.H. Orkin, A protein in-
teraction network for pluripotency of embryonic stem cells, Nature 444 (2006)
364–368.
[32] D.L. van den Berg, T. Snoek, N.P. Mullin, A. Yates, K. Bezstarosti, J. Demmers, I.
Chambers, R.A. Poot, An Oct4-centered protein interaction network in embryonic
stem cells, Cell Stem Cell 6 (2010) 369–381.
[33] T.G. Gabig, P.L. Mantel, R. Rosli, C.D. Crean, Requiem: a novel zinc ﬁnger gene essen-
tial for apoptosis in myeloid cells, J. Biol. Chem. 269 (1994) 29515–29519.
[34] Y. Lim, V.X. Seah,A.Mantalaris,M.G. Yap, D.C.Wong, Elucidating the role of requiem in
the growth and death of Chinese hamster ovary cells, Apoptosis 15 (2010) 450–462.
[35] T. Tando, A. Ishizaka, H.Watanabe, T. Ito, S. Iida, T. Haraguchi, T. Mizutani, T. Izumi, T.
Isobe, T. Akiyama, J. Inoue, H. Iba, Requiem protein links RelB/p52 and the Brm-type
SWI/SNF complex in a noncanonical NF-kappaB pathway, J. Biol. Chem. 285 (2010)
21951–21960.
[36] C. Tallant, E. Valentini, O. Fedorov, L. Overvoorde, F.M. Ferguson, P. Filippakopoulos,
D.I. Svergun, S. Knapp, A. Ciulli, Molecular basis of histone tail recognition by human
TIP5 PHD ﬁnger and bromodomain of the chromatin remodeling complex NoRC,
Structure 23 (2015) 80–92.
[37] J.G. Rack, T. Lutter, G.E. Kjaereng Bjerga, C. Guder, C. Ehrhardt, S. Varv, M. Ziegler, R.
Aasland, The PHD ﬁnger of p300 inﬂuences its ability to acetylate histone and non-
histone targets, J. Mol. Biol. 426 (2014) 3960–3972.
[38] M. Bienz, The PHD ﬁnger, a nuclear protein-interaction domain, Trends Biochem.
Sci. 31 (2006) 35–40.
[39] J. Wang, A.G. Muntean, L. Wu, J.L. Hess, A subset of mixed lineage leukemia proteins
has plant homeodomain (PHD)-mediated E3 ligase activity, J. Biol. Chem. 287
(2012) 43410–43416.
[40] X. Qiu, B.E. Dul, N.C. Walworth, Activity of a C-terminal plant homeodomain (PHD)
of Msc1 is essential for function, J. Biol. Chem. 285 (2010) 36828–36835.
[41] D. Uchida, S. Hatakeyama, A. Matsushima, H. Han, S. Ishido, H. Hotta, J. Kudoh, N.
Shimizu, V. Doucas, K.I. Nakayama, N. Kuroda, M. Matsumoto, AIRE functions as an
E3 ubiquitin ligase, J. Exp. Med. 199 (2004) 167–172.
[42] Z. Lu, S. Xu, C. Joazeiro, M.H. Cobb, T. Hunter, The PHD domain of MEKK1 acts as an
E3 ubiquitin ligase and mediates ubiquitination and degradation of ERK1/2, Mol.
Cell 9 (2002) 945–956.
[43] L. Coscoy, D.J. Sanchez, D. Ganem, A novel class of herpesvirus-encoded membrane-
bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune
recognition, J. Cell Biol. 155 (2001) 1265–1273.
[44] E.W. Hewitt, L. Duncan, D. Mufti, J. Baker, P.G. Stevenson, P.J. Lehner, Ubiquitylation
of MHC class I by the K3 viral protein signals internalization and TSG101-dependent
degradation, EMBO J. 21 (2002) 2418–2429.
[45] X. Chen, Z. Du, W. Shi, C. Wang, Y. Yang, F. Wang, Y. Yao, K. He, A. Hao, 2-
Bromopalmitate modulates neuronal differentiation through the regulation of his-
tone acetylation, Stem Cell Res. 12 (2014) 481–491.[46] A. Apostolou, Y. Shen, Y. Liang, J. Luo, S. Fang, Armet, a UPR-upregulated protein, in-
hibits cell proliferation and ER stress-induced cell death, Exp. Cell Res. 314 (2008)
2454–2467.
[47] H. Yang, C. Liu, Y. Zhong, S. Luo, M.J. Monteiro, S. Fang, Huntingtin interacts with the
cue domain of gp78 and inhibits gp78 binding to ubiquitin and p97/VCP, PLoS One 5
(2010), e8905.
[48] L. Liu, C. Liu, Y. Zhong, A. Apostolou, S. Fang, ER stress response during the differen-
tiation of H9 cells induced by retinoic acid, Biochem. Biophys. Res. Commun. 417
(2012) 738–743.
[49] C. Liu, Y. Sun, J. Arnold, B. Lu, S. Guo, Synergistic contribution of SMAD signaling
blockade and high localized cell density in the differentiation of neuroectoderm
from H9 cells, Biochem. Biophys. Res. Commun. 452 (2014) 895–900.
[50] S. Dan, B. Kang, X. Duan, Y.-J. Wang, A cell-free system toward deciphering the post-
translational modiﬁcation barcodes of Oct4 in different cellular contexts, Biochem.
Biophys. Res. Commun. 456 (2015) 714–720.
[51] S. Fang, M. Ferrone, C. Yang, J.P. Jensen, S. Tiwari, A.M. Weissman, The tumor auto-
crine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degra-
dation from the endoplasmic reticulum, Proc. Natl. Acad. Sci. U. S. A. 98 (2001)
14422–14427.
[52] J. Fan, H. Ren, N. Jia, E. Fei, T. Zhou, P. Jiang, M.Wu, G.Wang, DJ-1 decreases Bax expres-
sion through repressing p53 transcriptional activity, J. Biol. Chem. 283 (2008)
4022–4030.
[53] Z.W. Du, S.C. Zhang, Lentiviral vector-mediated transgenesis in human embryonic
stem cells, Methods Mol. Biol. 614 (2010) 127–134.
[54] N. Matsuda, T. Suzuki, K. Tanaka, A. Nakano, Rma1, a novel type of RING ﬁnger pro-
tein conserved from Arabidopsis to human, is a membrane-bound ubiquitin ligase, J.
Cell Sci. 114 (2001) 1949–1957.
[55] R. Paolini, R. Molfetta, M. Piccoli, L. Frati, A. Santoni, Ubiquitination and degradation
of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engage-
ment, Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9611–9616.
[56] P. Gupta, P.C. Ho, M.M. Huq, S.G. Ha, S.W. Park, A.A. Khan, N.P. Tsai, L.N.Wei, Retinoic
acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of
nuclear receptor TR2 to suppress Oct4 expression, Proc. Natl. Acad. Sci. U. S. A. 105
(2008) 11424–11429.
[57] R. Spelat, F. Ferro, F. Curcio, Serine 111 phosphorylation regulates OCT4A protein
subcellular distribution and degradation, J. Biol. Chem. 287 (2012) 38279–38288.
[58] P. van der Stoop, E.A. Boutsma, D. Hulsman, S. Noback, M. Heimerikx, R.M.
Kerkhoven, J.W. Voncken, L.F. Wessels, M. van Lohuizen, Ubiquitin E3 ligase
Ring1b/Rnf2 of polycomb repressive complex 1 contributes to stable maintenance
of mouse embryonic stem cells, PLoS One 3 (2008), e2235.
[59] C. Liu, D. Zhang, Y. Shen, X. Tao, L. Liu, Y. Zhong, S. Fang, Data in support of DPF2 reg-
ulates OCT4 protein level and nuclear distribution, Data Brief (2015) (submitted for
publication).
[60] R.T. Wagner, A.J. Cooney, OCT4: less is more, Cell Res. 19 (2009) 527–528.
[61] R.T. Rodriguez, J.M. Velkey, C. Lutzko, R. Seerke, D.B. Kohn, K.S. O'Shea, M.T. Firpo,
Manipulation of OCT4 levels in human embryonic stem cells results in induction
of differential cell types, Exp. Biol. Med. (Maywood) 232 (2007) 1368–1380.
[62] Y. Yao, Y. Lu, W.C. Chen, Y. Jiang, T. Cheng, Y. Ma, L. Lu, W. Dai, Cobalt and nickel sta-
bilize stem cell transcription factor OCT4 through modulating its sumoylation and
ubiquitination, PLoS One 9 (2014), e86620.
[63] M. Schoenhals, A. Kassambara, J. De Vos, D. Hose, J. Moreaux, B. Klein, Embryonic
stem cell markers expression in cancers, Biochem. Biophys. Res. Commun. 383
(2009) 157–162.
[64] X.Q. Wang, W.M. Ongkeko, L. Chen, Z.F. Yang, P. Lu, K.K. Chen, J.P. Lopez, R.T. Poon,
S.T. Fan, Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver can-
cer cells through a potential Oct4–AKT–ATP–binding cassette G2 pathway,
Hepatology 52 (2010) 528–539.
[65] B. Liao, X. Zhong, H. Xu, F. Xiao, Z. Fang, J. Gu, Y. Chen, Y. Zhao, Y. Jin, Itch, an E3 ligase
of Oct4, is required for embryonic stem cell self-renewal and pluripotency induc-
tion, J. Cell. Physiol. 228 (2013) 1443–1451.
[66] B. Liao, Y. Jin, Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination
in a dosage-dependent manner, Cell Res. 20 (2010) 332–344.
[67] J.P. Saxe, A. Tomilin, H.R. Scholer, K. Plath, J. Huang, Post-translational regulation of
Oct4 transcriptional activity, PLoS One 4 (2009), e4467.
[68] W. Li, Y. Ye, Polyubiquitin chains: functions, structures, and mechanisms, Cell. Mol.
Life Sci. 65 (2008) 2397–2406.
[69] R. Ben-Saadon, D. Zaaroor, T. Ziv, A. Ciechanover, The polycomb protein Ring1B gen-
erates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase
activity, Mol. Cell 24 (2006) 701–711.
[70] K. Haglund, I. Dikic, Ubiquitylation and cell signaling, EMBO J. 24 (2005) 3353–3359.
[71] C. Liu, E. Fei, N. Jia, H. Wang, R. Tao, A. Iwata, N. Nukina, J. Zhou, G. Wang, Assembly
of lysine 63-linked ubiquitin conjugates by phosphorylated alpha-synuclein implies
Lewy body biogenesis, J. Biol. Chem. 282 (2007) 14558–14566.
[72] P. Xu, D.M. Duong, N.T. Seyfried, D. Cheng, Y. Xie, J. Robert, J. Rush, M. Hochstrasser,
D. Finley, J. Peng, Quantitative proteomics reveals the function of unconventional
ubiquitin chains in proteasomal degradation, Cell 137 (2009) 133–145.
[73] K. Ohnishi, K. Semi, T. Yamamoto, M. Shimizu, A. Tanaka, K. Mitsunaga, K. Okita, K.
Osafune, Y. Arioka, T. Maeda, H. Soejima, H. Moriwaki, S. Yamanaka, K. Woltjen, Y.
Yamada, Premature termination of reprogramming in vivo leads to cancer develop-
ment through altered epigenetic regulation, Cell 156 (2014) 663–677.
[74] H.R. Scholer, S. Ruppert, N. Suzuki, K. Chowdhury, P. Gruss, New type of POU domain
in germ line-speciﬁc protein Oct-4, Nature 344 (1990) 435–439.
[75] F. Wei, H.R. Scholer, M.L. Atchison, Sumoylation of Oct4 enhances its stability, DNA
binding, and transactivation, J. Biol. Chem. 282 (2007) 21551–21560.
